Concepedia

Daniel Yerly

DY

25

Publications

1.5K

Citations

21

H-Index

2008

Active since

Affiliations

University Hospital of Bern(Current)

University of Bern

Swiss Red Cross

ADR-AC (Switzerland)

Harvard University

Daniel Yerly is an author at University Hospital of Bern specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

2008–2022

25

Publications

25

Oxypurinol Directly and Immediately Activates the Drug-Specific T Cells via the Preferential Use of HLA-B*58:01

James Yun, María J. Marcaida, Klara Eriksson et al. · The Journal of Immunology · 2014 · 154 citations · Full text

, , +19

Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response

James Yun, Jonas Mattsson, Klara Schnyder et al. · Clinical & Experimental Allergy · 2013 · 128 citations · Full text

Human “T <sub>H</sub> 9” cells are a subpopulation of PPAR-γ <sup>+</sup> T <sub>H</sub> 2 cells

C. Micossé, Leonhard von Meyenn, Oliver Steck et al. · Science Immunology · 2019 · 116 citations

HLA Haplotype Determines Hapten or p-i T Cell Reactivity to Flucloxacillin

Natascha Wuillemin, Jacqueline Adam, Stefano Fontana et al. · The Journal of Immunology · 2013 · 105 citations · Full text

, , +19

Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis

Sabine Adler, Stephan Reichenbach, Andrea D. Gloor et al. · Lara D. Veeken · 2019 · 104 citations

Rows per page

1–5 of 25